Butylamine

Butylamine

SCHEMBL28820128

CCCCN.Oc1ccc(C2CCNCC2)c(O)c1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 5/20 0.40
TYR P14679 3/20 0.39
QDPR P09417 1/20 0.38
HTR1A P08908 7/20 0.38
DRD1 P21728 7/20 0.38
DRD4 P21917 7/20 0.38
DRD5 P21918 7/20 0.38
DRD3 P35462 7/20 0.38
DRD2 P14416 6/20 0.38
MEN1 O00255 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX5 P09917 1/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HTR2C P28335 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8315420 0.84 QDPR (0.50) IKBKBTYRQDPRMEN1CYP3A4
Hydrochloric Acid SCHEMBL1979199 0.82 QDPR (0.49) IKBKBQDPRHTR2C
SCHEMBL28134205 0.74 SLC6A2 (0.43) QDPRHTR2C
SCHEMBL6709234 0.74 TRPA1 (0.47) QDPRHTR1ADRD1DRD2HTR2C
SCHEMBL19249421 0.72 TYR (0.48) TYRMEN1CYP3A4MAPTKMT2A
SCHEMBL24310183 0.71 USP7 (0.52) QDPRHTR1AHTR2C
SCHEMBL31131399 0.71 HTR2C (0.58) QDPRHTR2C
SCHEMBL19347098 0.71 HTR2C (0.58) QDPRHTR2C
SCHEMBL6707255 0.71 HTR2C (0.54) QDPRHTR1AMEN1KMT2AHTR2C
SCHEMBL8313932 0.71 QDPR (0.55) QDPRCYP3A4HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104666299-A 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof GALDERMA RES & DEV 2015-06-03 CN disclosed